Trial Profile
Organ Function Preservation by the Combination Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients: OPTIMUM Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms OPTIMUM
- 12 Mar 2017 Status changed from recruiting to completed.
- 21 Feb 2012 Planned end date changed from 1 Aug 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov.
- 22 Jul 2010 New trial record